Mweemba O, Maman S, Freeborn K, Hazwela C, Kamat A, Kumwenda A, Lusaka M, Matenga TFL, Namukanga NE, Rosenberg NR, Chi BH, Mutale W. Perspectives and experiences of Zambian pregnant and postpartum women receiving two intervention models to increase uptake of male partner HIV testing. Glob Public Health. 2023 Aug 8;18(1). doi: 10.1080/17441692.2023.2242463
Ten Eyck L, MacLeod S, Hawkins K, Guimont R, Hartley S. The impact of a heart failure management program in a medicare advantage population. Popul Health Manag. 2019 Apr;22(2):153-61. doi: 10.1089/pop.2018.0072
Bennett KJ, Probst JC, Bullard JC, Crouch E. The importance of rural hospitals: transfers and 30-day readmissions among rural residents and patients presenting at rural hospitals. Popul Health Manag. 2019 Apr;22(2):120-6. doi: 10.1089/pop.2018.0050
MacLeod S, Schwebke K, Hawkins K, Ruiz J, Hoo E, Yeh CS. Need for comprehensive health care quality measures for older adults. Popul Health Manag. 2018 Aug;21(4):296-302. doi: 10.1089/pop.2017.0109
Davis AE, Brogan AJ, Goodwin B, Nocea G, Lozano V. Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain. HIV Clin Trials. 2017 Nov;18(5-6):214-22. doi: 10.1080/15284336.2017.1402144
Rajan SS, Suryavanshi MS, Karanth S, Lairson DR. The immediate impact of the 2009 USPSTF screening guideline change on physician recommendation of a screening mammogram: findings from a national ambulatory and medical care survey-based study. Popul Health Manag. 2017 Apr;20(2):155-64. doi: 10.1089/pop.2015.0180.
Mehta H, Patel J, Parikh RC, Abughosh S. Differences in obesity management among physicians. Popul Health Manag. 2012 Oct;15(5):287-92.
Brogan AJ, Mrus J, Hill A, Sawyer AW, Smets E. Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United States. HIV Clin Trials. 2010 May;11(3):133-44.